CVS Health Corporation

68.48+0.5300+0.78%Vol 6.98M1Y Perf -33.21%
Dec 1st, 2023 16:00 DELAYED
BID68.25 ASK68.58
Open67.91 Previous Close67.95
Pre-Market- After-Market68.50
 - -  0.02 0.03%
Target Price
117.25 
Analyst Rating
Moderate Buy 1.60
Potential %
71.22 
Finscreener Ranking
     40.97
Insiders Trans % 3/6/12 mo.
-100/-89/-79 
Value Ranking
     39.01
Insiders Value % 3/6/12 mo.
-100/-99/-98 
Growth Ranking
★+     42.32
Insiders Shares Cnt. % 3/6/12 mo.
-100/-99/-98 
Income Ranking
     30.45
Price Range Ratio 52W %
10.07 
Earnings Rating
Sell
Market Cap88.13B 
Earnings Date
1st Nov 2023
Alpha-0.00 Standard Deviation0.07
Beta0.58 

Today's Price Range

67.3768.64

52W Range

64.41104.83

5 Year PE Ratio Range

-89.2019.20

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-1.35%
1 Month
-1.67%
3 Months
4.28%
6 Months
-2.16%
1 Year
-33.21%
3 Years
-1.65%
5 Years
-14.61%
10 Years
5.69%

TickerPriceChg.Chg.%
CVS68.480.53000.78
AAPL191.241.29000.68
GOOG133.32-0.6000-0.45
MSFT374.51-4.4000-1.16
XOM102.990.25000.24
WFC45.020.43000.96
JNJ158.383.72002.41
FB196.640.99000.51
GE122.500.70000.57
JPM156.840.76000.49
Financial StrengthValueIndustryS&P 500US Markets
0.60
0.90
0.49
1.01
2.70
Leverage Ratio 3.20
ProfitabilityValueIndustryS&P 500US Markets
17.20
2.00
3.40
2.90
0.78
RevenueValueIndustryS&P 500US Markets
238.62B
181.60
9.47
11.35
DividendsValueIndustryS&P 500US Markets
2.65
2.42
0.24
1.44
Payout ratio35.00
Earnings HistoryEstimateReportedSurprise %
Q03 20232.132.213.76
Q02 20232.122.214.25
Q01 20232.072.206.28
Q04 20221.921.993.65
Q03 20221.992.095.03
Q02 20222.162.4011.11
Q01 20222.142.223.74
Q04 20211.941.982.06
Earnings Per EndEstimateRevision %Trend
12/2023 QR1.98-2.94Negative
12/2023 FY8.59-0.12Negative
3/2024 QR2.04-5.12Negative
12/2024 FY8.54-1.95Negative
Next Report Date-
Estimated EPS Next Report2.13
Estimates Count11
EPS Growth Next 5 Years %4.50
Volume Overview
Volume6.98M
Shares Outstanding1.29M
Shares Float1.07B
Trades Count74.69K
Dollar Volume476.71M
Avg. Volume6.89M
Avg. Weekly Volume6.65M
Avg. Monthly Volume6.94M
Avg. Quarterly Volume7.10M

CVS Health Corporation (NYSE: CVS) stock closed at 68.48 per share at the end of the most recent trading day (a 0.78% change compared to the prior day closing price) with a volume of 6.98M shares and market capitalization of 88.13B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 300000 people. CVS Health Corporation CEO is Karen S. Lynch.

The one-year performance of CVS Health Corporation stock is -33.21%, while year-to-date (YTD) performance is -26.52%. CVS stock has a five-year performance of -14.61%. Its 52-week range is between 64.41 and 104.83, which gives CVS stock a 52-week price range ratio of 10.07%

CVS Health Corporation currently has a PE ratio of 39.10, a price-to-book (PB) ratio of 1.70, a price-to-sale (PS) ratio of 0.50, a price to cashflow ratio of 5.50, a PEG ratio of 8.69, a ROA of 1.47%, a ROC of 3.37% and a ROE of 4.72%. The company’s profit margin is 0.78%, its EBITDA margin is 3.40%, and its revenue ttm is $238.62 Billion , which makes it $181.60 revenue per share.

Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.13 for the next earnings report. CVS Health Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.6), with a target price of $117.25, which is +71.22% compared to the current price. The earnings rating for CVS Health Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CVS Health Corporation has a dividend yield of 2.65% with a dividend per share of $2.42 and a payout ratio of 35.00%.

CVS Health Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 8.38, ATR14 : 1.42, CCI20 : -44.96, Chaikin Money Flow : 0.06, MACD : -0.30, Money Flow Index : 53.70, ROC : 1.00, RSI : 48.64, STOCH (14,3) : 67.53, STOCH RSI : 0.69, UO : 57.59, Williams %R : -32.48), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Karen S. Lynch (Buy at a value of $976 500), Ludwig Edward (Buy at a value of $140 940), Thomas M. Moriarty (Option Excercise at a value of $10 151 220), Thomas M. Moriarty (Sold 137 466 shares of value $13 521 179 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
13 (61.90 %)
13 (61.90 %)
11 (55.00 %)
Moderate Buy
3 (14.29 %)
3 (14.29 %)
3 (15.00 %)
Hold
5 (23.81 %)
5 (23.81 %)
6 (30.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.60
Moderate Buy
1.60
Moderate Buy
1.73

CVS Health Corporation

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with over 23 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

CEO: Karen S. Lynch

Telephone: +1 401 765-1500

Address: One CVS Drive, Woonsocket 02895, RI, US

Number of employees: 300 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

55%45%

Bearish Bullish

57%43%

 

TipRanks News for CVS


News

Stocktwits